Structure of N-(5-ethyl-[1,3,4]-thiadiazole-2-yl)-toluenesulfonamide by combined X-ray powder diffraction, 13C solid-state NMR and molecular modelling

Acta Crystallographica Section B: Structural Science

Volumn 66, Issue 6, 2010, Pages 615-621

  Hangan, Adriana ^a   Borodi, Gheorghe ^b   Filip, Xenia ^b   Tripon, Carmen ^b   Morari, Cristian ^b   Oprean, Luminita ^a   Filip, Claudiu ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NATIONAL INSTITUTE FOR RESEARCH AND DEVELOPMENT OF ISOTOPIC AND MOLECULAR TECHNOLOGIES   (Romania)

Author keywords

cross polarization magic angle spinning; gauge including projector augmented wave method; X ray powder diffraction

Indexed keywords

DATA REDUCTION; DIFFRACTION; GAGES; MOLECULAR MODELING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGANIC COMPOUNDS; POLARIZATION; SOLID STATE PHYSICS; X RAY POWDER DIFFRACTION; X RAYS;

ASYMMETRIC UNIT; CROSS POLARIZATIONS; DATA ANALYSIS; DOUBLE STRANDS; GAUGE INCLUDING PROJECTOR AUGMENTED WAVES; MICROCRYSTALLINE POWDERS; MOLECULAR MODELLING; MULTI-TECHNIQUE APPROACH; NON-COVALENT INTERACTION; SOLID STATE NMR; SPACE GROUPS; STRUCTURE SOLUTIONS; SUPRAMOLECULAR ARRANGEMENT; THIADIAZOLES; TITLE COMPOUNDS;

CRYSTAL STRUCTURE;

DRUG DERIVATIVE; N (5 ETHYL (1,3,4) THIADIAZOLE 2 YL)TOLUENESULFONAMIDE; N-(5-ETHYL-(1,3,4)-THIADIAZOLE-2-YL)TOLUENESULFONAMIDE; SULFONAMIDE; TOLUENE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HYDROGEN BOND; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POWDER DIFFRACTION; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

CRYSTALLOGRAPHY, X-RAY; HYDROGEN BONDING; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; POWDER DIFFRACTION; SULFONAMIDES; TOLUENE; X-RAY DIFFRACTION;

EID: 78649627773     PISSN: 01087681     EISSN: 01087681     Source Type: Journal    
DOI: 10.1107/S0108768110039327     Document Type: Article

References (32)

1. Aluas, M., Tripon, C., Griffin, J. M., Filip, X., Ladizhansky, V., Griffin, R. G., Brown, S. P. & Filip, C. (2009). J. Magn. Reson. 199, 173-187.
2. Balimann, G. E., Groombridge, C. J., Harris, R. K., Packer, K. J., Say, B. J. & Tanner, S. F. (1981). Philos. Trans. R. Soc. London Ser. A, 299, 643-663.
3. Boultif, A. & Louër, D. (2004). J. Appl. Cryst. 37, 724-731.
4. Bugay, D. E. (2001). Adv. Drug Deliv. Rev. 48, 43-65.
5. David, W. I. F., Shankland, K., van de Streek, J., Pidcock, E., Motherwell, W. D. S. & Cole, J. C. (2006). J. Appl. Cryst. 39, 910-915.
6. De Paepe, G, Lesage, A., Steuernagel, S. & Emsley, L. (2004). Chem. Phys. Chem. 5, 869-875.
7. Finger, L. W., Cox, D. E. & Jephcoat, A. P. (1994). J. Appl. Cryst. 27, 892-900.
8. Frisch, M. J. et al. (2004). GAUSSIAN03, Revision C.02. Gaussian, Inc., Wallingford, CT, USA.
9. Garcia-Gimenez, J. L., Alzuet, G, Gonzalez-Alvarez, M., Liu-Gonzalez, M., Castineiras, A. & Borras, J. (2009). J. Inorg. Biochem. 103, 243-255.
10. Giannozzi, P. et al. (2009). J. Phys. Condens. Matter, 21, 395502.
11. Hangan, A., Borras, J., Liu-Gonzalez, M. & Oprean, L. (2009). Rev. Chim. 8, 755-759.
12. Harris, K. D. M., Tremayne, M. & Kariuki, B. M. (2001). Angew. Chem. Int. Ed. 40, 1626-1651.
13. Harris, R. K., Hodgkinson, P., Pickard, C.J., Yates, J. R. & Zorin, V. (2007). Magn. Reson. Chem. 45, S174-S186.
14. Harris, R. K., Joyce, S., Pickard, C. J., Cadars, S. & Emsley, L. (2006). Phys. Chem. Chem. Phys. 8, 137-143.
15. Larson, A. C. & Von Dreele, R. B. (2000). LAUR. Los Alamos National Laboratory Report. Los Alamos, New Mexico, USA.
16. Laugier, J. & Bochu, B. (2000). CHECKCELL, Collaborative Computational Project Number 14 (CCP14). Laboratoire des Materiaux et du Génie Physique de l'Ecole Supérieure de Physique de Grenoble, France.
17. Middleton, D. A., Peng, X., Saunders, D, Shankland, K., David, W. I. F. & Markvardsen, A. J. (2002). Chem. Commun. 17, 1976-1977.
18. Miertus, S., Scrocco, E. & Tomasi, J. (1981). Chem. Phys. 55, 117-129.
19. McCusker, L. B., Von Dreele, R. B., Cox, D. E., Louër, D. & Scardi, P. (1999). J. Appl. Cryst. 32, 36-50.
20. Nishio, M., Hirota, M. & Umezawa, Y. (1998). The CH/π Interaction, Evidence, Nature and Consequences. New York: Wiley-VCH.
21. Offerdahl, T. J. & Munson, E. J. (2004). Am. Pharm. Rev. 7, 109.
22. Reutzel-Edens, S. M. & Bush, J. K. (2002). Am. Pharm. Rev. 5, 112.
23. Segal, M. D, Lindan, P. J. D, Probert, M. J., Pickard, C. J., Hasnip, P. J., Clark, S. J. & Payne, M. C. (2002). J. Phys. Condens. Matter, 14, 2717-2744.
24. Soler, J. M., Artacho, E., Gale, J. D, Garcia, A., Junquera, J., Ordejon, P. & Sanchez-Portal, D. (2002). J. Phys. Condens. Matter, 14, 2745-2780.
25. Supuran, C. T. (2008). Nat. Rev. Drug Discov. 7, 168-181.
26. Tam, C. N, Cowan, J. A., Schultz, A. J., Young, V.G. Jr, Trouw, F. R. & Sykes, A. G. (2003). J. Phys. Chem. B, 107, 7601-7606.
27. Tishmack, P. A., Bugay, D. E. & Bryn, S. R. (2003). J. Pharm. Sci. 92, 441-474.
28. Thompson, P., Cox, D. E. & Hastings, J. B. (1987). J. Appl. Cryst. 20, 79-83.
29. Toby, B. H. (2001). J. Appl. Cryst. 34, 210-213.
30. Zheng, A., Liu, S. B. & Deng, F. (2008). J. Comput. Chem. 30, 222-235.
31. Zhigang, P., Cheung, E. Y, Harris, K. D. M., Constable, E. C. & Housecroft, C. E. (2005). Cryst. Growth Des. 5, 2084-2090.
32. Wu, A., Zhang, Y, Xu, X. & Yan, Y. (2007). J. Comput. Chem. 28, 2431-2442.